An increase in the TIPM3 and RECK protein levels (3.21- and 1.35-fold increase respectively) and a decrease in the MMP2 protein level (0.46-fold) indicated that overexpression of CLEC19A reduced the ability of U87 cancer cell migration (Fig. 4K). The gene discussed is CLEC19A; the disease is cancer.